{"id":117364,"date":"2021-06-19T11:00:00","date_gmt":"2021-06-19T11:00:00","guid":{"rendered":"https:\/\/icrowdnewswire.com\/?p=2882280"},"modified":"2021-06-19T11:00:00","modified_gmt":"2021-06-19T11:00:00","slug":"refractory-angina-epidemiology-forecast-insights-into-disease-overview-patient-pool-prevalence-and-futuristic-outlook-delveinsight","status":"publish","type":"post","link":"https:\/\/ipsnews.net\/business\/2021\/06\/19\/refractory-angina-epidemiology-forecast-insights-into-disease-overview-patient-pool-prevalence-and-futuristic-outlook-delveinsight\/","title":{"rendered":"Refractory Angina Epidemiology Forecast: Insights into Disease Overview, Patient Pool, Prevalence, and Futuristic Outlook | DelveInsight"},"content":{"rendered":"<p><img decoding=\"async\" width=\"200\" height=\"200\" src=\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/06\/5353-Delveinsight20Logo-1.jpg\" class=\"webfeedsFeaturedVisual wp-post-image\" alt=\"\" loading=\"lazy\" style=\"display: block; margin-bottom: 5px; clear:both;max-width: 100%;\" link_thumbnail=\"\" \/><\/p>\n<p><a title=\"Refractory Angina Epidemiology\" href=\"https:\/\/www.delveinsight.com\/sample-request\/refractory-angina-epidemiology-forecast?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=apr\" target=\"_blank\" rel=\"noopener noreferrer\"><img decoding=\"async\" style=\"margin-left: auto; margin-right: auto;\" src=\"https:\/\/beta-kiosk.icrowdnewswire.com\/assets\/source\/users\/delveinsight\/Refractory-Angina-Epidemiology-Forecast.jpg?1623991303233\" alt=\"Refractory-Angina-Epidemiology-Forecast\" \/><\/a><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/refractory-angina-epidemiology-forecast?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=apr\"><strong>Refractory Angina<\/strong><\/a><span style=\"font-weight: 400;\"> is a rare, chronic, and progressive form of pulmonary hypertension characterized by elevated pulmonary arterial pressure (PAP) &amp; pulmonary vascular resistance (PVR) in blood vessels carrying the blood through the lungs from the right side of the heart. It occurs due to the stiffening and tightening of the small pulmonary arteries leading to the right ventricular dysfunction and vessel obstruction.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">DelveInsight&#8217;s &#8216;<\/span><a href=\"https:\/\/www.delveinsight.com\/report-store\/refractory-angina-epidemiology-forecast?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=apr\"><strong>Refractory Angina Epidemiology<\/strong><\/a><strong> Forecast to 2030&#8242;<\/strong><span style=\"font-weight: 400;\"> report delivers an in-depth understanding of the disease, historical &amp; forecasted Refractory Angina epidemiology in the 7MM: The United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.<\/span><\/p>\n<p><strong>Key Facts of the <\/strong><a href=\"https:\/\/www.delveinsight.com\/report-store\/refractory-angina-epidemiology-forecast?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=apr\"><strong>Refractory Angina Epidemiology Report<\/strong><\/a><strong>:<\/strong><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">DelveInsight estimates that the <strong>highest prevalence<\/strong> of Refractory Angina in the USA is in patients with <strong>Class III sub-type<\/strong>. It had more than <strong>13,00,000 cases in 2020.<\/strong><\/span><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.delveinsight.com\/report-store\/refractory-angina-epidemiology-forecast?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=apr\"><span style=\"font-weight: 400;\">Refractory Angina prevalence<\/span><\/a><span style=\"font-weight: 400;\"> for the patients with Class IV was more than 5,00,000 cases in 2020 that is projected to increase in 2030.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Among EU5, <strong>Germany<\/strong> had the <strong>highest<\/strong> population of Refractory Angina followed by the <strong>UK<\/strong>.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">According to DelveInsight&#8217;s analysis, Refractory Angina is more prominent in <strong>males<\/strong> in comparison to <strong>females<\/strong>.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Refractory Angina prevalent population in <strong>Jap<\/strong><\/span><span style=\"font-weight: 400;\"><strong>an<\/strong> was more than <strong>150,000 cases in 2020.<\/strong><\/span><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><strong>Request for Free Sample Report: <\/strong><a href=\"https:\/\/www.delveinsight.com\/sample-request\/refractory-angina-epidemiology-forecast?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=apr\"><strong>https:\/\/www.delveinsight.com\/sample-request\/refractory-angina-epidemiology-forecast<\/strong><\/a><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/refractory-angina-epidemiology-forecast?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=apr\"><strong>Refractory Angina<\/strong><\/a><span style=\"font-weight: 400;\"> is characterized by similar symptoms that appear during heart and lung conditions. Therefore, several techniques and blood tests such as Chest X-Ray, Blood Tests, Cardiac Catheterization, Electrocardiogram, and Echocardiogram are used for diagnosing PAH.&nbsp;<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Cardiac Catheterization is the process that involves the insertion of a thin tube into a vein of the neck. Right heart catheterization is used for measuring the amount of pressure developed in pulmonary arteries. It is also used for assessing the functioning of the heart.&nbsp;<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Blood tests are mostly recommended to determine the presence of connective tissue disease, Human Immunodeficiency Virus (HIV) infection, and Sickle Cell Anemia.<\/span><\/p>\n<p><strong><em>&#8220;<\/em><\/strong><strong>Refractory Angina<\/strong><strong><em> is classified on the basis of grading the pain. Among these sub-types, Class III contributes the major patient share of RA followed by Class IV angina.&#8221;<\/em><\/strong><\/p>\n<p><strong>Request for Free Sample Report: <\/strong><a href=\"https:\/\/www.delveinsight.com\/sample-request\/refractory-angina-epidemiology-forecast?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=apr\"><strong>https:\/\/www.delveinsight.com\/sample-request\/refractory-angina-epidemiology-forecast<\/strong><\/a><\/p>\n<p><strong>Scope of the <\/strong><a href=\"https:\/\/www.delveinsight.com\/report-store\/refractory-angina-epidemiology-forecast?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=apr\"><strong>Refractory Angina Report<\/strong><\/a><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Refractory Angina report covers a detailed overview of its causes, symptoms, pathophysiology, classification, diagnosis, &amp; treatment patterns.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Refractory Angina Epidemiology Report &amp; Model provide an overview of the global trends and risk factors of Refractory Angina in the 7MM: The United States, France, Germany, Spain, UK, Italy, and Japan)<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">The report provides insight into the historical &amp; forecasted Refractory Angina patient pool in 7MM covering the United States, EU5 (Germany, Italy, Spain, France, UK) &amp; Japan<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">The <\/span><a href=\"https:\/\/www.delveinsight.com\/report-store\/refractory-angina-epidemiology-forecast?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=apr\"><span style=\"font-weight: 400;\">Refractory Angina report <\/span><\/a><span style=\"font-weight: 400;\">helps to recognize the growth opportunities of Refractory Angina in the 7MM with respect to the patient population<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">The Refractory Angina report assesses the risk factors, burden &amp; highlights the unmet needs of Refractory Angina disease.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">The Refractory Angina report provides the segmentation of the Refractory Angina epidemiology.<\/span><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><strong>Request for Free Sample Report: <\/strong><a href=\"https:\/\/www.delveinsight.com\/sample-request\/refractory-angina-epidemiology-forecast?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=apr\"><strong>https:\/\/www.delveinsight.com\/sample-request\/refractory-angina-epidemiology-forecast<\/strong><\/a><\/p>\n<p><strong>Key <\/strong><a href=\"https:\/\/www.delveinsight.com\/report-store\/refractory-angina-epidemiology-forecast?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=apr\"><strong>Refractory Angina Epidemiology<\/strong><\/a><strong> Questions Covered:<\/strong><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">What will be the market growth opportunities in the 7MM with respect to the Refractory Angina patient population?<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">What are the key findings related to the Refractory Angina epidemiology across seven major markets &amp; which country will have the highest number of Refractory Angina patients during the forecast period (2018-2030)?<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">What would be the total number of Refractory Angina patients across the 7MM during the forecast period (2018-2030)?<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">&nbsp;Among the EU5 countries, which country will have the highest number of Refractory Angina patients during the forecast period (2018-2030)?<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">At what CAGR the Refractory Angina patient population is expected to grow by 7MM during the forecast period (2018-2030)?<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">What are the disease risk, burden, and unmet needs of Refractory Angina?<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">What are the currently Refractory Angina treatments available?<\/span><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><strong>Request for Free Sample Report: <\/strong><a href=\"https:\/\/www.delveinsight.com\/sample-request\/refractory-angina-epidemiology-forecast?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=apr\"><strong>https:\/\/www.delveinsight.com\/sample-request\/refractory-angina-epidemiology-forecast<\/strong><\/a><\/p>\n<p><strong>Related Reports:&nbsp;<\/strong><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/refractory-angina-pipeline-insight?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=apr\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Refractory Angina Pipeline<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">The Refractory Angina report provides an overview of therapeutic pipeline activity and therapeutic assessment of the products by development stage, product type, route of administration, molecule type, and MOA type for Refractory Angina across the complete product development cycle, including all clinical and non-clinical stages.<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/refractory-angina-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=apr\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Refractory Angina Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">The Refractory Angina market report provides current treatment practices, emerging drugs, Refractory Angina market share of the individual therapies, current and forecasted Refractory Angina Market Size from <strong>2018 to 2030<\/strong> segmented by seven major markets.<\/span><\/p>\n<p><strong>Get in touch with our Business executive for Rich and Deep<\/strong><a href=\"https:\/\/www.delveinsight.com\/consulting?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\"> <span style=\"font-weight: 400;\">Healthcare Consulting<\/span><\/a><strong> Solutions<\/strong><\/p>\n<p><strong>Latest Blogs:<\/strong><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/blog\/medtech-news-and-updates\/\"><strong>MedTech Industry: Commercial, Regulatory and Clinical Updates<\/strong><\/a><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/blog\/hereditary-deafness-market\/\"><strong>Who is Going to be a Trendsetter in the Hereditary Deafness Market?<\/strong><\/a><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/blog\/substance-use-disorder-sud-treatment-market\/\"><strong>The Rising Burden of Substance Use Disorder And The Treatment Scenario<\/strong><\/a><\/p>\n<p><strong>Other Links:<\/strong><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.delveinsight.com\/report-store\/bipolar-disorder-manic-depression-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\"><strong>Bipolar Depression Market<\/strong><\/a><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.delveinsight.com\/report-store\/corneal-endothelial-dystrophy-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\"><strong>Corneal Endothelial Dystrophy Market<\/strong><\/a><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.delveinsight.com\/report-store\/endometriosis-pain-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\"><strong>Endometriosis Pain Market<\/strong><\/a><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.delveinsight.com\/report-store\/hepatic-encephalopathy-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\"><strong>Hepatic Encephalopathy Market<\/strong><\/a><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.delveinsight.com\/report-store\/higher-risk-chronic-myelomonocytic-leukemia-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\"><strong>Higher-Risk Chronic Myelomonocytic Leukemia Market<\/strong><\/a><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.delveinsight.com\/report-store\/palmar-hyperhidrosis-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\"><strong>Palmar Hyperhidrosis Market<\/strong><\/a><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.delveinsight.com\/report-store\/west-syndrome-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\"><strong>West Syndrome Market<\/strong><\/a><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.delveinsight.com\/report-store\/binge-eating-disorders-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\"><strong>Binge Eating Disorder Market<\/strong><\/a><\/li>\n<\/ul>\n<p><strong>About <\/strong><a href=\"https:\/\/www.delveinsight.com\/?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\"><span style=\"font-weight: 400;\">DelveInsight<\/span><\/a><\/p>\n<p><span style=\"font-weight: 400;\">DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.&nbsp; Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform <\/span><a href=\"https:\/\/www.pharmdelve.com\/?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\"><span style=\"font-weight: 400;\">PharmDelve<\/span><\/a><span style=\"font-weight: 400;\">.<\/span><\/p>\n<p><strong>Connect With Us at:<\/strong><\/p>\n<p><strong>&nbsp;<\/strong><a href=\"https:\/\/www.linkedin.com\/company\/delveinsight-business-research-llp\/\"><span style=\"font-weight: 400;\">LinkedIn<\/span><\/a><strong> |<\/strong><a href=\"https:\/\/www.facebook.com\/delveinsightindia\/\"><span style=\"font-weight: 400;\"> Facebook<\/span><\/a><strong> |<\/strong><a href=\"https:\/\/twitter.com\/delve_insight\"><span style=\"font-weight: 400;\"> Twitter<\/span><\/a><\/p>\n<p class=\"tags\">Tags: <a href=\"https:\/\/icrowdnewswire.com\/tag\/refractory-angina-market\/\" rel=\"tag\">Refractory Angina Market<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/refractory-angina\/\" rel=\"tag\">Refractory Angina<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/refractory-angina-epidemiology\/\" rel=\"tag\">Refractory Angina Epidemiology<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/refractory-angina-prevalence\/\" rel=\"tag\">Refractory Angina Prevalence<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/refractory-angina-population\/\" rel=\"tag\">Refractory Angina Population<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/refractory-angina-diagnosis\/\" rel=\"tag\">Refractory Angina Diagnosis<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/refractory-angina-symptoms\/\" rel=\"tag\">Refractory Angina Symptoms<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/refractory-angina-treatment\/\" rel=\"tag\">Refractory Angina Treatment<\/a> <\/p>\n<div><strong>See Campaign: <\/strong><a href=\"https:\/\/www.delveinsight.com\/report-store\/refractory-angina-epidemiology-forecast\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/www.delveinsight.com\/report-store\/refractory-angina-epidemiology-forecast<\/a><br \/><b>Contact Information:<\/b><br \/>\u00a0Ankit Nigam \u00a0info@delveinsight.com \u00a0+91-9650213330<\/p>\n<p><b>Tags:<\/b><br \/><a href=\"\"><\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/menafn\/\" rel=\"category tag\">Menafn<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/ips\/\" rel=\"category tag\">IPS<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/reportedtimes\/\" rel=\"category tag\">Reportedtimes<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/news-category\/icn-internal-distribution\/\" rel=\"category tag\">iCN Internal Distribution<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/news-category\/extended-distribution\/\" rel=\"category tag\">Extended Distribution<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/news-category\/research-newswire\/\" rel=\"category tag\">Research Newswire<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/language\/english\/\" rel=\"category tag\">English<\/a><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"\" alt=\"image\" width=\"400\" height=\"300\" class=\"cwdfimg\" \/><\/div>\n<div>\n<h3>Contact Information:<\/h3>\n<p>\u00a0Ankit Nigam<br \/> \u00a0info@delveinsight.com<br \/> \u00a0+91-9650213330<\/p>\n<\/p>\n<\/div>\n<p>The post <a rel=\"nofollow\" href=\"https:\/\/heymuse.com\/refractory-angina-epidemiology-forecast-insights-into-disease-overview-patient-pool-prevalence-and-futuristic-outlook-delveinsight\/\">Refractory Angina Epidemiology Forecast: Insights into Disease Overview, Patient Pool, Prevalence, and Futuristic Outlook | DelveInsight<\/a> appeared first on <a rel=\"nofollow\" href=\"https:\/\/heymuse.com\">Financial Market Brief<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Refractory Angina is a rare, chronic, and progressive form of pulmonary hypertension characterized by elevated pulmonary arterial pressure (PAP) &amp; pulmonary vascular resistance (PVR) in blood vessels carrying the blood through the lungs from the right side of the heart. It occurs due to the stiffening and tightening of the small pulmonary arteries leading to [&hellip;]<\/p>\n<p>The post <a rel=\"nofollow\" href=\"https:\/\/heymuse.com\/refractory-angina-epidemiology-forecast-insights-into-disease-overview-patient-pool-prevalence-and-futuristic-outlook-delveinsight\/\">Refractory Angina Epidemiology Forecast: Insights into Disease Overview, Patient Pool, Prevalence, and Futuristic Outlook | DelveInsight<\/a> appeared first on <a rel=\"nofollow\" href=\"https:\/\/heymuse.com\/\">Financial Market Brief<\/a>.<\/p>\n<p> <a href=\"https:\/\/ipsnews.net\/business\/2021\/06\/19\/refractory-angina-epidemiology-forecast-insights-into-disease-overview-patient-pool-prevalence-and-futuristic-outlook-delveinsight\/\" class=\"more-link\">Continue Reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":291,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[],"class_list":["post-117364","post","type-post","status-publish","format-standard","hentry","category-press-release"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Refractory Angina Epidemiology Forecast: Insights into Disease Overview, Patient Pool, Prevalence, and Futuristic Outlook | DelveInsight - Business<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"http:\/\/ipsnews.net\/business\/2021\/06\/19\/refractory-angina-epidemiology-forecast-insights-into-disease-overview-patient-pool-prevalence-and-futuristic-outlook-delveinsight\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Refractory Angina Epidemiology Forecast: Insights into Disease Overview, Patient Pool, Prevalence, and Futuristic Outlook | DelveInsight - Business\" \/>\n<meta property=\"og:description\" content=\"Refractory Angina is a rare, chronic, and progressive form of pulmonary hypertension characterized by elevated pulmonary arterial pressure (PAP) &amp; pulmonary vascular resistance (PVR) in blood vessels carrying the blood through the lungs from the right side of the heart. It occurs due to the stiffening and tightening of the small pulmonary arteries leading to [&hellip;] The post Refractory Angina Epidemiology Forecast: Insights into Disease Overview, Patient Pool, Prevalence, and Futuristic Outlook | DelveInsight appeared first on Financial Market Brief. Continue Reading &rarr;\" \/>\n<meta property=\"og:url\" content=\"http:\/\/ipsnews.net\/business\/2021\/06\/19\/refractory-angina-epidemiology-forecast-insights-into-disease-overview-patient-pool-prevalence-and-futuristic-outlook-delveinsight\/\" \/>\n<meta property=\"og:site_name\" content=\"Business\" \/>\n<meta property=\"article:published_time\" content=\"2021-06-19T11:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/06\/5353-Delveinsight20Logo-1.jpg\" \/>\n<meta name=\"author\" content=\"iCrowdNewswire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"iCrowdNewswire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"http:\/\/ipsnews.net\/business\/2021\/06\/19\/refractory-angina-epidemiology-forecast-insights-into-disease-overview-patient-pool-prevalence-and-futuristic-outlook-delveinsight\/\",\"url\":\"http:\/\/ipsnews.net\/business\/2021\/06\/19\/refractory-angina-epidemiology-forecast-insights-into-disease-overview-patient-pool-prevalence-and-futuristic-outlook-delveinsight\/\",\"name\":\"Refractory Angina Epidemiology Forecast: Insights into Disease Overview, Patient Pool, Prevalence, and Futuristic Outlook | DelveInsight - Business\",\"isPartOf\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#website\"},\"primaryImageOfPage\":{\"@id\":\"http:\/\/ipsnews.net\/business\/2021\/06\/19\/refractory-angina-epidemiology-forecast-insights-into-disease-overview-patient-pool-prevalence-and-futuristic-outlook-delveinsight\/#primaryimage\"},\"image\":{\"@id\":\"http:\/\/ipsnews.net\/business\/2021\/06\/19\/refractory-angina-epidemiology-forecast-insights-into-disease-overview-patient-pool-prevalence-and-futuristic-outlook-delveinsight\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/06\/5353-Delveinsight20Logo-1.jpg\",\"datePublished\":\"2021-06-19T11:00:00+00:00\",\"author\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee\"},\"breadcrumb\":{\"@id\":\"http:\/\/ipsnews.net\/business\/2021\/06\/19\/refractory-angina-epidemiology-forecast-insights-into-disease-overview-patient-pool-prevalence-and-futuristic-outlook-delveinsight\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"http:\/\/ipsnews.net\/business\/2021\/06\/19\/refractory-angina-epidemiology-forecast-insights-into-disease-overview-patient-pool-prevalence-and-futuristic-outlook-delveinsight\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"http:\/\/ipsnews.net\/business\/2021\/06\/19\/refractory-angina-epidemiology-forecast-insights-into-disease-overview-patient-pool-prevalence-and-futuristic-outlook-delveinsight\/#primaryimage\",\"url\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/06\/5353-Delveinsight20Logo-1.jpg\",\"contentUrl\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/06\/5353-Delveinsight20Logo-1.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\/\/ipsnews.net\/business\/2021\/06\/19\/refractory-angina-epidemiology-forecast-insights-into-disease-overview-patient-pool-prevalence-and-futuristic-outlook-delveinsight\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ipsnews.net\/business\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Refractory Angina Epidemiology Forecast: Insights into Disease Overview, Patient Pool, Prevalence, and Futuristic Outlook | DelveInsight\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ipsnews.net\/business\/#website\",\"url\":\"https:\/\/ipsnews.net\/business\/\",\"name\":\"Business\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ipsnews.net\/business\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee\",\"name\":\"iCrowdNewswire\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g\",\"caption\":\"iCrowdNewswire\"},\"sameAs\":[\"https:\/\/heymuse.com\/ips\"],\"url\":\"https:\/\/ipsnews.net\/business\/author\/icrowdnewswire\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Refractory Angina Epidemiology Forecast: Insights into Disease Overview, Patient Pool, Prevalence, and Futuristic Outlook | DelveInsight - Business","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"http:\/\/ipsnews.net\/business\/2021\/06\/19\/refractory-angina-epidemiology-forecast-insights-into-disease-overview-patient-pool-prevalence-and-futuristic-outlook-delveinsight\/","og_locale":"en_US","og_type":"article","og_title":"Refractory Angina Epidemiology Forecast: Insights into Disease Overview, Patient Pool, Prevalence, and Futuristic Outlook | DelveInsight - Business","og_description":"Refractory Angina is a rare, chronic, and progressive form of pulmonary hypertension characterized by elevated pulmonary arterial pressure (PAP) &amp; pulmonary vascular resistance (PVR) in blood vessels carrying the blood through the lungs from the right side of the heart. It occurs due to the stiffening and tightening of the small pulmonary arteries leading to [&hellip;] The post Refractory Angina Epidemiology Forecast: Insights into Disease Overview, Patient Pool, Prevalence, and Futuristic Outlook | DelveInsight appeared first on Financial Market Brief. Continue Reading &rarr;","og_url":"http:\/\/ipsnews.net\/business\/2021\/06\/19\/refractory-angina-epidemiology-forecast-insights-into-disease-overview-patient-pool-prevalence-and-futuristic-outlook-delveinsight\/","og_site_name":"Business","article_published_time":"2021-06-19T11:00:00+00:00","og_image":[{"url":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/06\/5353-Delveinsight20Logo-1.jpg","type":"","width":"","height":""}],"author":"iCrowdNewswire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"iCrowdNewswire","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"http:\/\/ipsnews.net\/business\/2021\/06\/19\/refractory-angina-epidemiology-forecast-insights-into-disease-overview-patient-pool-prevalence-and-futuristic-outlook-delveinsight\/","url":"http:\/\/ipsnews.net\/business\/2021\/06\/19\/refractory-angina-epidemiology-forecast-insights-into-disease-overview-patient-pool-prevalence-and-futuristic-outlook-delveinsight\/","name":"Refractory Angina Epidemiology Forecast: Insights into Disease Overview, Patient Pool, Prevalence, and Futuristic Outlook | DelveInsight - Business","isPartOf":{"@id":"https:\/\/ipsnews.net\/business\/#website"},"primaryImageOfPage":{"@id":"http:\/\/ipsnews.net\/business\/2021\/06\/19\/refractory-angina-epidemiology-forecast-insights-into-disease-overview-patient-pool-prevalence-and-futuristic-outlook-delveinsight\/#primaryimage"},"image":{"@id":"http:\/\/ipsnews.net\/business\/2021\/06\/19\/refractory-angina-epidemiology-forecast-insights-into-disease-overview-patient-pool-prevalence-and-futuristic-outlook-delveinsight\/#primaryimage"},"thumbnailUrl":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/06\/5353-Delveinsight20Logo-1.jpg","datePublished":"2021-06-19T11:00:00+00:00","author":{"@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee"},"breadcrumb":{"@id":"http:\/\/ipsnews.net\/business\/2021\/06\/19\/refractory-angina-epidemiology-forecast-insights-into-disease-overview-patient-pool-prevalence-and-futuristic-outlook-delveinsight\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["http:\/\/ipsnews.net\/business\/2021\/06\/19\/refractory-angina-epidemiology-forecast-insights-into-disease-overview-patient-pool-prevalence-and-futuristic-outlook-delveinsight\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"http:\/\/ipsnews.net\/business\/2021\/06\/19\/refractory-angina-epidemiology-forecast-insights-into-disease-overview-patient-pool-prevalence-and-futuristic-outlook-delveinsight\/#primaryimage","url":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/06\/5353-Delveinsight20Logo-1.jpg","contentUrl":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/06\/5353-Delveinsight20Logo-1.jpg"},{"@type":"BreadcrumbList","@id":"http:\/\/ipsnews.net\/business\/2021\/06\/19\/refractory-angina-epidemiology-forecast-insights-into-disease-overview-patient-pool-prevalence-and-futuristic-outlook-delveinsight\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ipsnews.net\/business\/"},{"@type":"ListItem","position":2,"name":"Refractory Angina Epidemiology Forecast: Insights into Disease Overview, Patient Pool, Prevalence, and Futuristic Outlook | DelveInsight"}]},{"@type":"WebSite","@id":"https:\/\/ipsnews.net\/business\/#website","url":"https:\/\/ipsnews.net\/business\/","name":"Business","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ipsnews.net\/business\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee","name":"iCrowdNewswire","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g","caption":"iCrowdNewswire"},"sameAs":["https:\/\/heymuse.com\/ips"],"url":"https:\/\/ipsnews.net\/business\/author\/icrowdnewswire\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/117364","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/users\/291"}],"replies":[{"embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/comments?post=117364"}],"version-history":[{"count":1,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/117364\/revisions"}],"predecessor-version":[{"id":117365,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/117364\/revisions\/117365"}],"wp:attachment":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/media?parent=117364"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/categories?post=117364"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/tags?post=117364"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}